乳腺X线筛查的使用及其与Medicare受益者后续预防服务使用的关系
该回顾性队列研究纳入2010至2014年美国Medicare索赔数据中555705例患者,其中185625例(33.4%)在2012年接受筛查乳腺X线检查。调整人口学、合并症、地理协变量和基线预防保健后,接受筛查者后续行Papanicolaou试验(OR 1.49;95%CI 1.40,1.58)、骨量测量(OR 1.70;95%CI 1.63,1.78)和流感疫苗接种(OR 1.45;95%CI 1.37,1.53)的可能性高于未筛查者;在筛查前2年未接受这些预防措施的妇女中,筛查假阳性结果后使用这三项服务与真阴性结果后无差异。
要点
- 接受筛查乳腺X线检查与后续Papanicolaou试验、骨量测量和流感疫苗接种的概率较高相关。
- 在筛查前2年未接受预防措施的妇女中,假阳性筛查结果后使用三项预防服务与真阴性结果后无差异。
- 本研究为回顾性队列研究,基于美国Medicare索赔数据,结果可能受未测量混杂因素影响。
核心结论
- 在美国Medicare受益者中,使用筛查乳腺X线检查与更遵守其他预防指南的可能性较高相关,且假阳性结果与宫颈癌筛查之间无负相关。
研究设计与样本
- 回顾性队列研究,基于2010至2014年美国Medicare索赔研究可识别文件,纳入555705例患者,其中185625例(33.4%)在2012年接受筛查乳腺X线检查;采用多变量logistic回归模型和逆概率治疗加权分析。
诊断标准与关键数值
- 筛查乳腺X线检查后2年内行Papanicolaou试验的OR为1.49(95%CI 1.40,1.58),骨量测量的OR为1.70(95%CI 1.63,1.78),流感疫苗接种的OR为1.45(95%CI 1.37,1.53);在筛查前2年未接受这些预防措施的妇女中,假阳性结果后使用三项服务与真阴性结果后无差异。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 本研究为回顾性研究。
- 结果可能受未测量混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To retrospectively assess whether there is an association between screening mammography and the use of a variety of preventive services in women who are enrolled in Medicare. Materials and Methods U.S. Medicare claims from 2010 to 2014 Research Identifiable Files were reviewed to retrospectively identify a group of women who underwent screening mammography and a control group without screening mammography in 2012. The screened group was divided into positive versus negative results at screening, and the positive subgroup was divided into false-positive and true-positive findings. Multivariate logistic regression models and inverse probability of treatment weighting were used to examine the relationship between screening status and the probabilities of undergoing Papanicolaou test, bone mass measurement, or influenza vaccination in the following 2 years. Results The cohort consisted of 555 705 patients, of whom 185 625 (33.4%) underwent mammography. After adjusting for patient demographics, comorbidities, geographic covariates, and baseline preventive care, women who underwent index screening mammography (with either positive or negative results) were more likely than unscreened women to later undergo Papanicolaou test (odds ratio [OR], 1.49; 95% confidence interval: 1.40, 1.58), bone mass measurement (OR, 1.70; 95% confidence interval: 1.63, 1.78), and influenza vaccine (OR, 1.45; 95% confidence interval: 1.37, 1.53). In women who had not undergone these preventive measures in the 2 years before screening mammography, use of these three services after false-positive findings at screening was no different than after true-negative findings at screening. Conclusion In beneficiaries of U.S. Medicare, use of screening mammography was associated with higher likelihood of adherence to other preventive guidelines, without a negative association between false-positive results and cervical cancer screening.
引用
- Kang SK, Jiang M, Duszak R, et al. Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries. Radiology. 2018. PMID: 29869958. doi:10.1148/radiol.2018172326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。